For over 56 years DIA’s global mission has been deeply rooted in neutrality, diversity, and inclusion.
We are deeply saddened by the recent tragedies in the US and the abhorrent biases they highlight. DIA strongly condemns such hateful behavior and stands against all forms of racism, discrimination, oppression, inequality, and injustice. We are committed to driving change and moving forward together, as a united, global community.
‹
›
DIA 2020 Virtual Global Annual Meeting is now LIVE!
Registered attendees may access DIA 2020 via the My Account Access Virtual Conference link. Click below for login help and access instructions.
New Podcast: FDA Deputy Commissioner for Medical and Scientific Affairs explains COVID-19 Clinical Trial Guidance - Safety of our DIA community remains our priority as we monitor the COVID-19 outbreak and follow updates from the WHO and others.
INSIDER ACCESS: DIA Member Exclusive - Who Owns My Health Data? Patients, Data, and the Future of R&D: Watch the video, follow the interactive transcript, or download the audio.
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
‹
›
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.
Get inside the minds of life science leaders as they share perspectives on current issues in healthcare product development, and the potential paths that lie ahead.